Thomas Stankovich - May 31, 2022 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
Chief Financial Officer
Signature
/s/ Thomas Stankovich
Stock symbol
RSLS
Transactions as of
May 31, 2022
Transactions value $
$18,422
Form type
4
Date filed
6/1/2022, 02:18 PM
Previous filing
May 12, 2022
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Purchase $67.90 +78 +0.02% $0.87 346K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $2.55K +2.9K +0.84% $0.88 349K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $178 +200 +0.06% $0.89 349K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $900 +1K +0.29% $0.90 350K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $7.36K +8K +2.29% $0.92 358K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $55.80 +60 +0.02% $0.93 358K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $6.15K +6.54K +1.83% $0.94 364K May 31, 2022 Direct
transaction RSLS Common Stock, $0.001 par value per share Purchase $1.17K +1.23K +0.34% $0.95 366K May 31, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.